Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 19, 2003
[Clinical characteristic of the elderly in influenza infection]Hideyuki Ikematsu
Human Vaccines & Immunotherapeutics|September 1, 2017
Is seasonal vaccination a contributing factor to the selection of influenza epidemic variants?Yong Chong, Hideyuki Ikematsu
Expert Review of Anti-Infective Therapy|October 7, 2011
Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenzaHideyuki Ikematsu, Naoki Kawai
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 9, 2017
Spread of predominant neuraminidase and hemagglutinin co-mutations in the influenza A/H3N2 virus genomeYong Chong, Hideyuki Ikematsu
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 29, 2012
In vitro neuraminidase inhibitory activities of four neuraminidase inhibitors against influenza viruses isolated in the 2010-2011 season in JapanHideyuki Ikematsu, Naoki Kawai, Seizaburo Kashiwagi
The Journal of Infectious Diseases|October 16, 2025
Use of Influenza Antivirals to Prevent TransmissionBenjamin J Cowling, Yun Lin, Hideyuki Ikematsu
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 28, 2015
Clinical outcome of laninamivir octanoate hydrate for influenza in the 2013-2014 Japanese seasonHideyuki Ikematsu, Naoki Kawai, Norio Iwaki, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 4, 2014
The duration of fever and other symptoms after the initiation of laninamivir octanoate hydrate in the Japanese 2011-2012 influenza seasonHideyuki Ikematsu, Naoki Kawai, Norio Iwaki, et al.
Pageof 11